CIK 0001191070 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Neuphoria Therapeutics Inc.
Sign in to watch- Ticker
- NEUP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- Australia
- Entity type
- operating
- Phone
- 781-439-5551
- Business address
- 100 SUMMIT DR, BURLINGTON, MA, 01803
- Former names
- BIONOMICS LIMITED/FI
- 8-K Event Material agreement · Shareholder rights changed
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement · Change in control · Regulation FD disclosure
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Material agreement · Agreement ended
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Delisting notice
Page 1 of 21 · 420 filings